Basics Black Diamond Therapeutics, Inc. IPO Date: January 31, 2020 Sector: Healthcare Industry: Biotech Market Cap: $142.16M Activated in VL: True Average Daily Range Avg Daily Range: $0.38 | 3.71% Avg Daily Range (30 D): $0.08 | 3.40% Avg Daily Range (90 D): $0.08 | 4.02% Institutional Daily Volume Avg Daily Volume: .65M Avg Daily Volume (30 D): 1.04M Avg Daily Volume (90 D): 2.38M Trade Size Avg Trade Size (Sh.): 132 Avg Trade Size (Sh.) (30 D): 179 Avg Trade Size (Sh.) (90 D): 223 Institutional Trades Total Inst.Trades: 370 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $3.32M Avg Inst. Trade (90 D): $2.62M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.28M Avg Closing Trade (30 D): $7.95M Avg Closing Trade (90 D): $4.23M Avg Closing Volume: 172.61K     News Mar 19, 2025 @ 11:00 AM Servier and Black Diamond Therapeutics AnnounceÂÂ... Source: N/A Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight Nov 5, 2024 @ 1:00 PM Black Diamond Therapeutics Reports Third Quarter 2... Source: N/A Oct 7, 2024 @ 8:01 PM Black Diamond Therapeutics Announces Restructuring... Source: N/A Sep 22, 2024 @ 2:00 PM Black Diamond Therapeutics to Host Webcast Present... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $.08 $1 $-.28 Diluted EPS $.06 $.98 $-.28 Revenue $ 70M $ 70M $ M Gross Profit $ $ $ Net Income / Loss $ 5.09M $ 56.54M $ -15.99M Operating Income / Loss $ -4.01M $ 54.53M $ -18.28M Cost of Revenue $ $ $ Net Cash Flow $ 73M $ 61.99M $ 13.01M PE Ratio 47.50